<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>Table 1</label>
 <caption>
  <p>Natural products tested against coronaviruses.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" align="left" rowspan="1" colspan="1">Plant (Family/part)</th>
    <th valign="top" align="center" rowspan="1" colspan="1">Product</th>
    <th valign="top" align="center" rowspan="1" colspan="1">Model/Strains</th>
    <th valign="top" align="center" rowspan="1" colspan="1">Inhibitory assay</th>
    <th valign="top" align="center" rowspan="1" colspan="1">Dosage/duration</th>
    <th valign="top" align="center" rowspan="1" colspan="1">Control</th>
    <th valign="top" align="center" rowspan="1" colspan="1">Effects</th>
    <th valign="top" align="center" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Alnus japonica</italic> (Thunb.) Steud.
     <break/>(Betulaceae/bark)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Hirsutenone
     <break/>(Ethanol extract)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- PLpro
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0–200 µM/60 min</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Curcumin (viral protease inhibitor)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">A dose-dependent inhibition of the SARS-CoV- PLpro activity (IC
     <sub>50</sub> = 4.1 ± 0.3 µM while that of curcumin was 5.7 ± 0.3 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B64" ref-type="bibr">Park et al., 2012b</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Angelica keiskei</italic> (Miq.) Koidz
     <break/>(Umbelliferae/leaves)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Xanthoangelol E
     <break/>(Ethanol extract)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- PLpro
     <break/>SARS-CoV- 3CL(pro)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET
     <break/>Cell-based cis-cleavage inhibition assay
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">0, 12.5, 25, 50 µM</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">A dose-dependent inhibition of SARS-CoV- PLpro activity
     <break/>(IC
     <sub>50</sub> = 1.2 ± 0.4 µM)
     <break/>A dose-dependent inhibition of SARS-CoV- 3CL(pro) activity (IC
     <sub>50</sub> = 11.4 ± 1.4 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B67" ref-type="bibr">Park et al., 2016</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Aglaia perviridis</italic> Hiern
     <break/>(Meliaceae/whole)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Myricetin</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>Angiotensin converting enzyme (ACE) from rabbit lung
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0.01–10 µM</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of the SARS-CoV helicase by affecting the ATPase activity
     <break/>(IC
     <sub>50</sub> = 2.71 ± 0.19 μM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B101" ref-type="bibr">Yu et al., 2012</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Cibotium barometz</italic> (L.) J.Sm.
     <break/>(Dicksoniaceae/rhizomes)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Ethanol and methanol extracts</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV virus propagated in Vero E6 cells
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Cytopathic effect inhibition
     <break/>ELISA
     <break/>FRET
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">0, 25, 50, 100, and 200 µg/ml</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Vero E6 cells without extracts (negative control)
     <break/>SARS-CoV-infected Vero E6 cells (positive control)
     <break/>Valinomycin (reference antiviral standard)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Both extracts inhibited the SARS-CoV- replication at concentrations of 25 and 200 μg/ml.
     <break/>EC
     <sub>50</sub> were found to be 8.42 and ≥10 µg/ml, respectively.
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B89" ref-type="bibr">Wen et al., 2011</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Cullen corylifolium (L.) Medik.
     <break/>(Leguminosae/seeds)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Psoralidin
     <break/>(Ethanol extract)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- PLpro
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Fluorogenic assay</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0–100µM</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of SARS-CoV PLpro in a dose-depenedent manner with IC
     <sub>50</sub> = 4.2 ± 1.0 µM
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B40" ref-type="bibr">Kim et al., 2014</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Ecklonia cava</italic>
     <break/>(Laminariaceae/whole)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Dieckol
     <break/>(Ethanol extract)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- 3CL(pro)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0–200 µM</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Positive controls:
     <break/>hesperetin (60 μM),
     <break/>daidzein (105 μM), aloeemodin (132 μM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of the SARS-CoV- 3CL(pro) activity
     <break/>(IC
     <sub>50</sub> = 2.7 ± 0.6 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B66" ref-type="bibr">Park et al., 2013</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Paulownia tomentosa</italic> (Thunb.) Steud.
     <break/>(Scrophulariaceae/fruits)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Tomentin E
     <break/>(Methanol extract)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- PLpro
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Fluorogenic assay</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0, 6.25, 12.5, 25 µM</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">A dose-dependent inhibition of SARS-CoV-PLpro (IC
     <sub>50</sub> = 5.0 ± 0.06 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B9" ref-type="bibr">Cho et al., 2013</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Quercus infectoria</italic> G. Olivier
     <break/>(Fagaceae/bark)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Ethanol-water extract</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Reverse phase high performance liquid chromatography (RP-HPLC)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">330 µg/ml</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Methanol solution (negative control)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of ACE activity by 93.9 ± 2.5%</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B76" ref-type="bibr">Sharifi et al., 2013</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Rheum</italic> sp.
     <break/>
     <italic>Polygonum</italic> sp.
     <break/>(Polygonaceae/whole)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Emodin</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>Vero cells
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Luciferase assay</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0, 10, 50, 100, 200, and 400 µM</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Blockage of the binding SARS-CoV S protein and ACE2
     <break/>Minimal active concentration: 10 µM
     <break/>IC
     <sub>50</sub> = 200 µM
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B28" ref-type="bibr">Ho et al., 2007</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="2" align="left" colspan="1">
     <italic>Salvia miltiorrhiza</italic> Bunge
     <break/>(Lamiaceae/roots)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Cryptotanshinone
     <break/>(n-hexane extract)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- PLpro
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0–200 µM/30 min</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">A dose- and time-dependent inhibition of the SARS-CoV- PLpro activity in a slow-binding inhibition mechanism
     <break/>(IC
     <sub>50</sub> = 0.8 ± 0.2 µM)
    </td>
    <td valign="top" rowspan="2" align="left" colspan="1">
     <xref rid="B63" ref-type="bibr">Park et al., 2012a</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Dihydrotanshinone I
     <break/>(n-hexane extract)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- 3CL(pro)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0–200 µM/60 min</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">A dose-dependent but not time-dependent inhibition of the SARS-CoV- 3CL(pro) activity (IC
     <sub>50</sub> = 14.4 ± 0.7 µM)
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="4" align="left" colspan="1">
     <italic>Sambucus javanica</italic> subsp. chinensis (Lindl.) Fukuoka
     <break/>(Adoxaceae/stem)
    </td>
    <td valign="top" align="center" rowspan="1" colspan="1">95% ethanol extract</td>
    <td valign="top" rowspan="4" align="left" colspan="1">
     <italic>In vitro</italic>
     <break/>HCoV-NL63 in LLC-MK2 cells
    </td>
    <td valign="top" rowspan="4" align="left" colspan="1">Cytopathic effect inhibition</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0, 1, 10, and 50 μg/ml/36 h</td>
    <td valign="top" rowspan="4" align="left" colspan="1">Virus-infection only with no test extract</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of:
     <break/>-Viral cytopathicity
     <break/>(IC
     <sub>50</sub> = 1.17 ± 0.75 μg/ml)
     <break/>-Virus attachment
     <break/>(IC
     <sub>50</sub> = 15.75 ± 6.65 μg/mL)
     <break/>-Plaque formation
     <break/>4.67 ± 1.21 μg/mL
    </td>
    <td valign="top" rowspan="4" align="left" colspan="1">
     <xref rid="B90" ref-type="bibr">Weng et al., 2019</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Caffeic acid</td>
    <td valign="top" rowspan="3" align="left" colspan="1">0, 10, 50, and 100 μM/36 h</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of viral cytopathicity
     <break/>(IC
     <sub>50</sub> = 3.54 ± 0.77 μM)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Chlorogenic acid</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of viral cytopathicity
     <break/>(IC
     <sub>50</sub> = 43.45 ± 6.01 μM)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Gallic acid</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of viral cytopathicity
     <break/>(IC
     <sub>50</sub> = 71.48 ± 18.40 μM)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Scutellaria baicalensis </italic>Georgi
     <break/>(Labiatae/whole)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Scutellarein</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0.01–10 µM</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of the SARS-CoV helicase by affecting the ATPase activity</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of the SARS-CoV helicase by affecting the ATPase activity
     <break/>(IC
     <sub>50</sub> = 0.86 ± 0.48 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B101" ref-type="bibr">Yu et al., 2012</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Torreya nucifera</italic> (L.) Siebold &amp; Zucc.
     <break/>(Taxaceae/leaves)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Amentoflavone
     <break/>(Ethanol extract)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- 3CL(pro)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0–300 µM</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Positive controls:
     <break/>Apigenin (IC
     <sub>50</sub> = 280.8 ± 21.4 µM)
     <break/>Luteolin (IC
     <sub>50</sub> = 20.0 ± 2.2 µM)
     <break/>Quercetin (IC
     <sub>50</sub> = 23.8 ± 1.9 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">A dose-dependent inhibition of SARS-CoV- 3CL(pro) activity
     <break/>(IC
     <sub>50</sub> = 8.3 ± 1.2 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B73" ref-type="bibr">Ryu et al., 2010</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Tribulus terrestris</italic> L.
     <break/>(Zygophyllaceae/fruits)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Terrestrimine
     <break/>(Methanol extract)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV PLpro
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Fluorogenic assay</td>
    <td valign="top" align="left" rowspan="1" colspan="1">1, 10, 100, 1,000 µM</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of SARS-CoV - PLpro with
     <break/>IC
     <sub>50</sub> = 15.8 ± 0.6 µM
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B81" ref-type="bibr">Song et al., 2014</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">———————</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Lianhuaqingwen
     <break/>(Herbal mixture) dissolved in DMSO and then in serum-free DMEM
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV-2 virus propagated in Vero E6 cells
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Cytopathic effect inhibition</td>
    <td valign="top" align="left" rowspan="1" colspan="1">0–600 µg/ml/72 h</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Remdesivir (5 µM)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibition of the SARS-CoV-2 replication
     <break/>(IC
     <sub>50</sub> = 412.2 µg/ml 
     <italic>vs</italic> 0.651 µM for the control)
     <break/>Inhibition of the plaque formation of the SARS-CoV-2
     <break/>Reduction of TNF-α, IL-6, CCL-2/MCP-1, and CXCL-10/IP-10 expression
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B72" ref-type="bibr">Runfeng et al., 2020</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>——————–</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Herbacetin</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- 3CL(pro)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">1, 2.5, 20 µM/16 h</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">A dose-dependent inhibition of SARS-CoV- 3CL(pro) activity
     <break/>(IC
     <sub>50</sub> = 33.17 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B35" ref-type="bibr">Jo et al., 2020</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>——————–</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Pectolinarin</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- 3CL(pro)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">1, 2.5, 20 µM/16 h</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">A dose-dependent inhibition of SARS-CoV- 3CL(pro) activity
     <break/>(IC
     <sub>50</sub> = 37.78 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B35" ref-type="bibr">Jo et al., 2020</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>——————–</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Rhoifolin</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic>
     <break/>SARS-CoV- 3CL(pro)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FRET</td>
    <td valign="top" align="left" rowspan="1" colspan="1">1, 2.5, 20 µM/16 h</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NS</td>
    <td valign="top" align="left" rowspan="1" colspan="1">A dose-dependent inhibition of SARS-CoV- 3CL(pro) activity
     <break/>(IC
     <sub>50</sub> = 27.45 µM)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B35" ref-type="bibr">Jo et al., 2020</xref>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>FRET, Fluorescence resonance energy transfer; GSEA, Microarray and Gene Set Enrichment Analysis; NS, Not specified.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
